TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 85 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $513 | -0.2% | 13,557 | 0.0% | 0.03% | -8.6% |
| Q2 2023 | $514 | +56.2% | 13,557 | 0.0% | 0.04% | +40.0% |
| Q1 2023 | $329 | -36.7% | 13,557 | -23.2% | 0.02% | -44.4% |
| Q4 2022 | $520 | -99.9% | 17,657 | 0.0% | 0.04% | -8.2% |
| Q3 2022 | $507,000 | -20.5% | 17,657 | 0.0% | 0.05% | -19.7% |
| Q2 2022 | $638,000 | -16.5% | 17,657 | 0.0% | 0.06% | -10.3% |
| Q1 2022 | $764,000 | -32.8% | 17,657 | -22.4% | 0.07% | -37.0% |
| Q4 2021 | $1,137,000 | -21.4% | 22,755 | 0.0% | 0.11% | -39.3% |
| Q3 2021 | $1,447,000 | -11.6% | 22,755 | 0.0% | 0.18% | -9.2% |
| Q2 2021 | $1,637,000 | -2.4% | 22,755 | 0.0% | 0.20% | -12.9% |
| Q1 2021 | $1,678,000 | +0.4% | 22,755 | 0.0% | 0.22% | -19.6% |
| Q4 2020 | $1,671,000 | +33.9% | 22,755 | 0.0% | 0.28% | +9.8% |
| Q3 2020 | $1,248,000 | -17.5% | 22,755 | 0.0% | 0.26% | -27.4% |
| Q2 2020 | $1,513,000 | +8.6% | 22,755 | 0.0% | 0.35% | -21.5% |
| Q1 2020 | $1,393,000 | -44.3% | 22,755 | -20.0% | 0.45% | -34.2% |
| Q4 2019 | $2,500,000 | +16.7% | 28,438 | 0.0% | 0.68% | +6.9% |
| Q3 2019 | $2,143,000 | -11.8% | 28,438 | 0.0% | 0.64% | -12.4% |
| Q2 2019 | $2,429,000 | -21.0% | 28,438 | 0.0% | 0.72% | -23.4% |
| Q1 2019 | $3,074,000 | +27.7% | 28,438 | 0.0% | 0.95% | +146.6% |
| Q4 2018 | $2,407,000 | -21.9% | 28,438 | -9.5% | 0.38% | -22.0% |
| Q3 2018 | $3,081,000 | -15.0% | 31,438 | 0.0% | 0.49% | -55.6% |
| Q2 2018 | $3,623,000 | +16.7% | 31,438 | 0.0% | 1.11% | +13.2% |
| Q1 2018 | $3,104,000 | -5.7% | 31,438 | 0.0% | 0.98% | -2.7% |
| Q4 2017 | $3,292,000 | -6.4% | 31,438 | 0.0% | 1.01% | -12.9% |
| Q3 2017 | $3,518,000 | -0.1% | 31,438 | 0.0% | 1.16% | -7.9% |
| Q2 2017 | $3,523,000 | -4.5% | 31,438 | 0.0% | 1.25% | -12.9% |
| Q1 2017 | $3,689,000 | +11.5% | 31,438 | 0.0% | 1.44% | -0.4% |
| Q4 2016 | $3,309,000 | -4.7% | 31,438 | 0.0% | 1.45% | -1.7% |
| Q3 2016 | $3,474,000 | -24.1% | 31,438 | 0.0% | 1.47% | -24.0% |
| Q2 2016 | $4,577,000 | +1.6% | 31,438 | -0.1% | 1.94% | -0.3% |
| Q1 2016 | $4,507,000 | -11.5% | 31,463 | -4.6% | 1.94% | -8.7% |
| Q4 2015 | $5,095,000 | +8.2% | 32,963 | 0.0% | 2.13% | +7.0% |
| Q3 2015 | $4,710,000 | -0.9% | 32,963 | -0.3% | 1.99% | +7.4% |
| Q2 2015 | $4,753,000 | -11.1% | 33,078 | -8.3% | 1.85% | -10.0% |
| Q4 2014 | $5,346,000 | – | 36,078 | – | 2.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL MANAGEMENT LP | 582,409 | $90,011,000 | 60.33% |
| GUARDIAN POINT CAPITAL, LP | 70,000 | $10,819,000 | 10.19% |
| Think Investments LP | 186,373 | $28,804,000 | 8.16% |
| Greywolf Capital Management LP | 277,936 | $42,955,000 | 7.45% |
| Valentine Capital Asset Management, Inc. | 28,431 | $4,394,000 | 4.91% |
| FORT, L.P. | 63,675 | $9,841,000 | 4.69% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 527,266 | $81,489,000 | 3.63% |
| RPG Investment Advisory, LLC | 60,910 | $9,413,000 | 3.52% |
| Kerrisdale Advisers, LLC | 81,996 | $12,672,000 | 3.24% |
| Strategic Global Advisors, LLC | 48,154 | $7,442,000 | 3.17% |